1004 Venture Partners empowers entrepreneurs with tools and invests in early-stage startup companies focused on healthy aging and transformative technologies in healthcare. The firm connects founders with its networks and provides mentorship.

1004 Venture Partners

MedTech World is a global event management company that organizes an annual investor and entrepreneur conference in the medtech and health tech sector in Malta, along with multiple roadshow events worldwide. It fosters collaboration among stakeholders to enhance healthcare.

MedTech World

1004 Venture Partners | 110 followers on LinkedIn. Healthy Aging Throughout Life | At 1004 Venture Partners, our mission is to transform the landscape of healthy aging investment. We specialize in identifying and nurturing cutting-edge, transformative technologies. Recognizing the challenges faced by entrepreneurs in early-stage startups, we are dedicated to providing the essential funding and resources needed for growth and success.

Our General Partner, Soyoung Park shared her thoughts about the future opportunities for the health data with the Big Tech industry at the LSI Europe 2024, at Sintra in Portugal.

Congrats to my partner Soyoung Park on her nomination as Female HealthTech Leader of the Year. She rocks.

We are proud that our General Partner, Soyoung Park , has been nominated for the Female HealthTech Leader of the Year award at the MedTech World Awards, which will be held at the Mediterranean Conference Centre in Malta on Friday, November 8th, 2024. We appreciate your support by voting for Soyoung for the MedTech Awards 2024! 🚨Voting is open until Monday, November 4th🎖️ https://lnkd.in/dyx5dWF5 #MedTechMalta24 #FemaleHealthTechLeaderoftheYear #MedTech #HealthTech #Leadetship

As an investor, you're often faced with a crucial decision: Do you bet on the jockey (the team) or the horse (the idea/market)? It's a question that's sparked countless debates in the venture capital world. Ideally, you want both a star team and a groundbreaking idea. But if pushed to choose, I lean towards the jockey. A great team can pivot a mediocre idea, but a weak team might fumble even the most promising opportunity. "What's your perspective? Are you Team Jockey or Team Horse? Share your thoughts below! 👇 #VentureCapital #StartupInvesting #EntrepreneurshipInsights

David H. Crean

https://lnkd.in/g7rQbMGT Interesting research posted this week in the journal Science on the use of Metformin, the most widely prescribed medication for diabetes, and its impact on aging.

Brilliant insights by Melanie Senior regarding the financing trends in Biotech. 1004 Venture Partners is expecting the waves of M&A in Biotech in 2025–2026 and encouraging prepared founders to get through the difficult time.

We are looking forward to the LSI Conference in September 2024 in which one of our General Partners Soyoung Park will be participating in a discussion centering on Agetech and the Global Aging Population.

Wonderful insights from reputable medtech leaders, including our own General Partner, Soyoung Park . https://lnkd.in/gzF66xpC #healthtech #medtech #innovation #FoundersvsMarkets

Time to increase the Healthspan against the extended Lifespan. #Logevity #Healthspan #HealthyAging

As a global fund, 1004 Venture Partners supports international entrepreneurs and looks forward to learning your transformative solutions. #interntionalfounders #USCISInterntionalEntrepreneurRule #GoGlobal

Metric
Company Name	1.00K	MedTech World
Symbol
MSH ID	COM:1004VENTUREPARTNERS	WORLD:MED-TECH
Market	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Commercial & Professional Services
Industry	Venture Capital	Event Management
Country	US	MT
Stage
Employee Count
Website	1004venturepartners.com	med-tech.world
LinkedIn	1004vp	mtw-medtech-world
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

1004

COM:1004VENTUREPARTNERS

1004 Venture Partners

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue